Eggs for Choline & Brain Function
Choline is the most under-supplied essential nutrient in the modern American diet. The 1998 Institute of Medicine adequate intake (AI) is 550 mg/day for adult men, 425 mg/day for adult women, and 450 mg/day in pregnancy — yet NHANES data consistently show that fewer than 10% of Americans meet the AI, and fewer than 5% of pregnant women do. A single large egg yolk supplies 147 mg of choline in its most bioavailable form (phosphatidylcholine). Two eggs a day puts an adult at roughly two-thirds of the AI from one food. The 2018 Caudill randomized trial showed that maternal supplementation at 930 mg/day during the third trimester improved infant information processing speed at four time points across the first year of life — a result that has shifted the discussion from "is choline important?" to "why isn't this routine prenatal advice?"
Table of Contents
- What Is Choline and Why Eggs?
- The Three Biochemical Roles of Choline
- Fetal Brain Development
- The Caudill 930 mg Trial
- Neural Tube Defects and Choline
- Adult Cognition and the Framingham Data
- Choline Deficiency and Non-Alcoholic Fatty Liver
- Practical Dosing — How Many Eggs?
- If You Don't Eat Eggs: Alternative Sources
- Cautions (TMAO, Genetic Variants, Upper Limit)
- Key Research Papers
- Connections
What Is Choline and Why Eggs?
Choline is a quaternary ammonium compound — a small water-soluble molecule that the body uses to build cell membranes (as phosphatidylcholine), to synthesize the neurotransmitter acetylcholine, and to donate methyl groups (via betaine) in the one-carbon metabolism cycle that handles DNA methylation and homocysteine recycling. The liver can synthesize a small amount of choline de novo by methylating phosphatidylethanolamine using S-adenosylmethionine, but this endogenous synthesis covers nowhere near the body's total requirement — choline must come from food.
For most of human evolutionary history, choline was abundant in the diet because organ meats, egg yolks, and animal fat were daily staples. The 20th-century shift away from these foods (driven first by the lipid hypothesis and then by industrial food economics) coincided with a measurable population-level drop in choline intake. The 1998 Institute of Medicine panel set the adequate intake based on the choline concentration in human breast milk, the smallest dose that prevented liver dysfunction in adult volunteer feeding studies, and the dose required to maintain choline status in pregnancy. The IOM was conservative — if anything, modern researchers like Steven Zeisel (who chaired the IOM panel) believe the AI is set too low for pregnancy and lactation.
Eggs are uniquely effective at delivering choline because:
- The yolk is concentrated. One large egg yolk (~17 g) contains roughly 147 mg of choline. Beef liver is denser (~420 mg per 100 g serving) but most Americans never eat liver. Eggs are eaten by nearly everyone.
- The form is phosphatidylcholine, not free choline. Roughly 80% of egg-yolk choline is bound into phosphatidylcholine, the same form used by the body's own cell membranes. Phosphatidylcholine is absorbed more efficiently than free choline chloride or choline bitartrate (the typical supplement forms), and bypasses the gut-microbiome conversion that produces trimethylamine (TMA), the precursor of the controversial cardiovascular biomarker TMAO.
- The cost is trivial. At ~30 US cents per egg, two eggs per day delivers ~300 mg of choline for ~60 cents. Equivalent choline from a supplement costs roughly the same per dose but lacks the additional protein, vitamins, lutein, and zeaxanthin you get from the whole food.
The Three Biochemical Roles of Choline
Choline functions in three distinct biochemical roles, and each maps to a different category of clinical effect when intake is inadequate.
- Phosphatidylcholine for cell membranes. Roughly 30% of all phospholipids in human cell membranes are phosphatidylcholine. The brain is the most lipid-dense organ in the body (roughly 60% lipid by dry weight), and a developing fetal brain requires enormous quantities of phosphatidylcholine to construct new neuronal membranes during the rapid third-trimester growth spurt. Adult brain membrane turnover is slower but ongoing, and inadequate choline impairs membrane repair and remyelination.
- Acetylcholine for neurotransmission. Acetylcholine is the neurotransmitter of the parasympathetic nervous system, the neuromuscular junction, and the cognitive cholinergic pathways from the basal forebrain (nucleus basalis of Meynert) that project to the cortex and hippocampus. The basal forebrain cholinergic system is the first system damaged in Alzheimer's disease, which is why the first-line Alzheimer's drugs (donepezil, rivastigmine, galantamine) are cholinesterase inhibitors that boost acetylcholine levels. Adequate dietary choline supports the synthesis of acetylcholine in these neurons.
- Betaine as a methyl donor in one-carbon metabolism. Choline is oxidized to betaine in the liver and kidney. Betaine then donates a methyl group to homocysteine, regenerating methionine and reducing homocysteine accumulation. This methyl-donor function overlaps with folate and Vitamin B12, and adequate choline can partially compensate for low folate intake (though not fully). Inadequate methyl donors lead to elevated homocysteine, hypomethylation of DNA, and dysregulation of gene expression.
The clinical effects of choline deficiency therefore span three organ systems: brain (cognitive impairment, neural tube defects), liver (steatosis from inability to package triglycerides into VLDL), and DNA methylation (epigenetic dysregulation, potentially relevant to cancer risk and fetal programming).
Fetal Brain Development
The fetal brain undergoes its most rapid growth in the third trimester. Between weeks 28 and 40, the brain triples in weight, the cortex undergoes dramatic gyrification, and synaptogenesis begins in earnest. This growth phase requires enormous quantities of phosphatidylcholine to build new neuronal membranes, choline for acetylcholine synthesis in developing cholinergic pathways, and methyl donors for the DNA methylation events that regulate neurogenesis.
The placenta actively transports choline from maternal blood to the fetus, with cord-blood choline concentrations roughly 3× maternal concentrations at term. This active transport explains why the maternal AI rises from 425 mg/day pre-pregnancy to 450 mg/day during pregnancy and 550 mg/day during lactation — the fetus and nursing infant are pulling choline directly out of maternal stores.
Rodent models established the developmental choline story first. Pregnant rats fed choline-supplemented diets gave birth to offspring with measurably enhanced hippocampal-dependent memory function that persisted into adulthood. Conversely, choline-deficient maternal diets produced offspring with permanent deficits in attention and visuospatial memory. The effect was both prenatal (third trimester equivalent) and postnatal (early lactation equivalent), and the mechanism appeared to involve permanent changes in hippocampal neurogenesis and in the epigenetic state of genes involved in synaptic plasticity.
The human translation took decades to demonstrate. Observational cohort studies (Boeke Project Viva, Strain Seychelles) found correlations between maternal choline intake or status and child cognitive performance years later, but observational data are vulnerable to confounding by overall maternal nutrition, education, and socioeconomic factors. The definitive evidence required a randomized controlled trial, which finally came in 2018.
The Caudill 930 mg Trial
In 2018, Marie Caudill and colleagues at Cornell published the most important choline trial in pregnancy to date. The design was randomized, controlled, double-blind. 24 pregnant women in the third trimester (week 27 onwards) were randomized to receive either 480 mg/day of choline (which equals the current pregnancy adequate intake when combined with typical background diet, putting total intake at the AI) or 930 mg/day (roughly twice the AI). Supplementation continued through delivery. Outcomes were measured in the infants at 4, 7, 10, and 13 months using a standardized infant information-processing-speed task (color-change visual paired-comparison paradigm).
Result: infants of mothers in the 930 mg/day arm showed significantly faster information processing speed at all four time points across the first year of life. The effect was robust, durable, and present even though the comparator arm was receiving the adequate intake (not zero choline). In other words, the current AI is insufficient for optimal fetal brain development — the higher dose produced a measurably better cognitive outcome.
The Caudill trial has not yet led to a change in official prenatal recommendations, but it has shifted clinical thinking. Many obstetricians and dietitians now suggest pregnant women aim for at least 550 mg/day of choline (the lactation AI) and ideally 900-1000 mg/day during the third trimester. This is achievable with three eggs per day plus typical background diet, or with prenatal vitamin supplementation that includes 500+ mg of phosphatidylcholine. Most prenatal vitamins, notably, contain little to no choline — a striking gap given the strength of the evidence.
For an earlier 2012 Caudill trial that pre-dated this work, see the Yan et al. paper on maternal and fetal choline biomarkers. The pre-2018 literature established that dietary choline alters fetal biomarker status; the 2018 trial established that it alters fetal cognitive outcomes.
Neural Tube Defects and Choline
Folate is the famous nutrient for preventing neural tube defects (anencephaly, spina bifida) — the United States has fortified the grain supply with folic acid since 1998 specifically to reduce NTD incidence, with dramatic success. Less well-known is that choline has a parallel and independent protective effect against NTDs, operating through the same one-carbon-metabolism pathway that folate occupies.
The pivotal observational study was Shaw et al. (2004), which used data from the California Birth Defects Monitoring Program to compare periconceptional dietary choline intake in mothers of NTD-affected pregnancies versus controls. Women in the lowest quartile of choline intake had approximately 4× the risk of an NTD-affected pregnancy compared to women in the highest quartile. The effect remained statistically significant after adjustment for folate intake, education, and other potential confounders — meaning the choline effect was independent of folate, not just a marker for overall nutrition.
The mechanism: NTDs occur when the neural tube fails to close completely during weeks 3-4 post-conception. Neural tube closure requires extensive DNA methylation events (controlled by methyl donors, which include both folate and choline via betaine), rapid membrane lipid synthesis (driven by phosphatidylcholine), and acetylcholine signaling in the early neuroectoderm. Folate handles the methylation arm. Choline handles the membrane lipid arm and provides additional methyl donor capacity. Both are necessary; neither alone is fully sufficient.
The practical implication: women trying to conceive should ensure adequate choline intake well before conception, ideally for at least 3 months prior. Three eggs per day combined with typical background diet reliably achieves this. Vegetarian women relying on plant choline sources (cruciferous vegetables, lentils, soybeans) need to be especially attentive to total intake because plant choline densities are lower than egg yolk by 5-10×.
For more on neural tube defect prevention, see our Folate page.
Adult Cognition and the Framingham Data
The Framingham Offspring Cohort — a multi-generational US epidemiological study originally launched in 1948 in the town of Framingham, Massachusetts — provided the most important adult-cognition data on choline through the Poly et al. (2011) analysis. Among 1,391 dementia-free participants aged 36 to 83 at baseline, current dietary choline intake (assessed by validated food frequency questionnaire) was associated with:
- Better performance on verbal memory and visual memory tests at the assessment time point. Effect sizes were modest but statistically robust.
- Lower volume of white matter hyperintensities on MRI — white matter hyperintensities are small areas of demyelination and ischemic damage visible on T2-weighted MRI that accumulate with age and correlate with cognitive decline. Participants in the highest quartile of choline intake had measurably fewer hyperintensities than those in the lowest quartile.
- Effects persisted after adjustment for age, education, total energy intake, B vitamins (folate, B6, B12), and other potential confounders.
The Framingham data are observational and cannot establish causation, but they are consistent with the mechanistic story: choline supports cholinergic neurotransmission (which underlies attention and memory), membrane lipid maintenance (which protects against demyelination), and methyl donor capacity (which supports DNA repair and homocysteine clearance, both linked to cognitive resilience).
The clinical translation for adults concerned about cognitive aging is straightforward. Achieving and maintaining adequate choline intake (550 mg/day for men, 425 mg/day for women, more if pregnant or lactating) is part of the same general nutritional pattern that supports brain health in aging: adequate omega-3 fatty acids (DHA), B vitamins, antioxidants, and protein. Two to three eggs per day is one of the simplest ways to ensure choline adequacy.
Choline Deficiency and Non-Alcoholic Fatty Liver
Non-alcoholic fatty liver disease (NAFLD) is now the most common chronic liver disease in the developed world, affecting roughly 25-30% of adults in the United States. The disease begins as benign hepatic steatosis (fat accumulation in liver cells) and progresses in a subset to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma.
Choline deficiency is a well-established cause of hepatic steatosis. The mechanism: the liver packages triglycerides for export to the bloodstream by wrapping them in very-low-density lipoprotein (VLDL) particles. The protein scaffold of a VLDL particle is apolipoprotein B-100, and its outer phospholipid monolayer is primarily phosphatidylcholine. Without adequate phosphatidylcholine (which requires adequate dietary choline as the rate-limiting substrate), the liver cannot construct VLDL fast enough to export the triglycerides it synthesizes. Triglycerides accumulate in hepatocytes — this is steatosis.
Volunteer feeding studies in the 1980s and 1990s established this directly. Healthy adult men fed choline-deficient diets developed measurable hepatic steatosis (assessed by liver function tests and imaging) within 3-6 weeks, and the steatosis reversed when choline was added back. The IOM 1998 panel based the adult AI partly on these volunteer studies — 550 mg/day was the smallest dose that reliably prevented steatosis development.
For patients with established NAFLD, choline adequacy is part of the nutritional management. The standard treatment is weight loss, the Mediterranean dietary pattern, and treatment of insulin resistance, but adequate choline intake removes one of the contributing mechanisms. Two to three eggs per day in a NAFLD patient is generally fine (it does not worsen the disease) and may modestly improve VLDL export capacity. For more on NAFLD, see our Fatty Liver Disease page.
Practical Dosing — How Many Eggs?
The arithmetic is straightforward. One large egg yolk delivers 147 mg of choline. The egg white delivers an additional 0.4 mg (negligible). Therefore:
- Adult man (AI 550 mg/day): 3 eggs supply ~441 mg (80% of AI); 4 eggs supply ~588 mg (107% of AI). Background diet typically provides 100-200 mg additional from grains, vegetables, meat, and dairy. Two to three eggs per day is sufficient for most men.
- Adult woman (AI 425 mg/day): 2 eggs supply ~294 mg (69% of AI); 3 eggs supply ~441 mg (104% of AI). Two eggs per day with normal background diet is sufficient for most women.
- Pregnant woman (AI 450 mg/day, but Caudill data suggest 900 mg/day for optimal fetal brain development): 3 eggs per day plus background diet hits the AI; reaching the Caudill 930 mg/day target requires 3 eggs plus an additional 400-500 mg from supplemental phosphatidylcholine or sunflower lecithin, since reaching that dose from food alone requires 5-6 eggs/day or 3-4 oz of beef liver weekly.
- Lactating woman (AI 550 mg/day): Same as adult man — 3 eggs per day is sufficient.
- Children: AI scales by age (200 mg/day at 1-3 years, 250 mg/day at 4-8, 375 mg/day at 9-13). One to two eggs per day is appropriate for most school-age children.
The Tolerable Upper Intake Level (UL) for choline is 3,500 mg/day in adults, set primarily based on fishy body odor and hypotension reported at doses above 7 g/day. Reaching the UL from food alone is essentially impossible — you would need to eat ~24 eggs per day. The UL is a safeguard against high-dose supplementation, not a concern for whole-food intake.
If You Don't Eat Eggs: Alternative Sources
Egg-free individuals (vegan, allergic, ethically opposed, or simply egg-averse) need to assemble their choline intake from a wider mix of sources. The densest non-egg sources are:
- Beef liver, 100 g serving: ~420 mg choline — the densest single source after egg yolk. One small serving per week meets a meaningful fraction of the weekly requirement.
- Salmon, 100 g serving: ~95 mg choline. See our Salmon page.
- Chicken breast, 100 g serving: ~73 mg choline.
- Beef, 100 g serving: ~70 mg choline. See our Beef page.
- Cod, 100 g serving: ~71 mg choline. See our Cod page.
- Soybeans, 1 cup cooked: ~107 mg choline.
- Quinoa, 1 cup cooked: ~43 mg choline.
- Lentils, 1 cup cooked: ~65 mg choline. See our Lentils page.
- Cruciferous vegetables (broccoli, Brussels sprouts, cauliflower), 1 cup cooked: 30-60 mg choline.
- Sunflower lecithin supplement: ~250-500 mg phosphatidylcholine per 1 tablespoon. The most efficient supplemental source for vegans and pregnant women aiming for the Caudill 930 mg/day target.
- Pure choline bitartrate or alpha-GPC supplements: 250-500 mg per capsule. More efficient than lecithin but lacks the additional phosphatidylcholine structure.
Vegan choline intake is typically half to one-third of omnivore intake without active attention. For pregnant or lactating vegans, supplemental phosphatidylcholine or sunflower lecithin is strongly advised. For nonpregnant vegan adults, combining soybeans, lentils, quinoa, and cruciferous vegetables daily can approach the AI, though reaching it consistently usually requires some supplementation or particularly thoughtful menu planning.
Cautions (TMAO, Genetic Variants, Upper Limit)
- The TMAO controversy. A series of papers from Stanley Hazen's group at Cleveland Clinic (starting around 2011) reported that gut microbes convert dietary phosphatidylcholine and L-carnitine into trimethylamine (TMA), which the liver oxidizes to TMAO (trimethylamine N-oxide), and that elevated serum TMAO is associated with increased cardiovascular event risk in observational cohorts. This generated alarm that eggs (and red meat) might be cardiovascularly harmful via the TMAO pathway. Subsequent work has substantially walked back this concern: (1) TMAO is also produced by gut microbes from fish (in fact, fish produces more TMAO than eggs); (2) the TMAO-cardiovascular association in observational studies appears to be confounded by kidney function (TMAO accumulates in CKD); (3) interventional studies feeding eggs to humans do not reliably increase TMAO unless the gut microbiome happens to have the relevant TMA-producing taxa; and (4) the gut-microbiome conversion can be modified by diet. Most cardiologists no longer consider TMAO a clinically actionable biomarker.
- Genetic variants in PEMT (phosphatidylethanolamine N-methyltransferase). Roughly 12% of women carry a common SNP (rs7946) in the PEMT gene that reduces estrogen-induced upregulation of endogenous choline synthesis. Carriers may have higher dietary choline requirements than the general population, particularly in pregnancy when PEMT activity normally surges to compensate for fetal demand. Genetic testing for PEMT variants is available through 23andMe and similar consumer panels.
- Fishy body odor at high doses. Choline doses above 7-10 g/day (from supplements, not realistically achievable from food) can cause fishy body odor in some individuals due to incomplete oxidation of trimethylamine. This is the basis for the IOM upper limit of 3,500 mg/day.
- Trimethylaminuria (TMAU) carriers. A rare metabolic disorder in which the FMO3 enzyme that oxidizes TMA to odorless TMAO is deficient. Affected individuals develop fish-odor syndrome at much lower choline doses and should restrict dietary choline. Prevalence is approximately 1 in 200,000.
- Hypotension at very high doses. Doses above 7 g/day can produce mild hypotension via vagal stimulation. Not relevant for food-based intake.
- Egg allergy. Egg allergy is the second-most-common food allergy in infants and young children (after cow's milk). Most children outgrow it by school age. The 2017 STEP trial (Palmer et al.) showed early egg introduction in eczema-affected infants under physician supervision can reduce later egg-allergy development.
Key Research Papers
- Caudill MA, Strupp BJ, Muscalu L, Nevins JEH, Canfield RL (2018). Maternal choline supplementation during the third trimester of pregnancy improves infant information processing speed: a randomized, double-blind, controlled feeding study. FASEB J. 32(4):2172-2180. — PubMed: Caudill 2018
- Shaw GM, Carmichael SL, Yang W, Selvin S, Schaffer DM (2004). Periconceptional dietary intake of choline and betaine and neural tube defects in offspring. Am J Epidemiol. 160(2):102-9. — PubMed: Shaw 2004
- Zeisel SH, da Costa KA (2009). Choline: an essential nutrient for public health. Nutr Rev. 67(11):615-23. — PubMed: Zeisel 2009
- Wallace TC, Fulgoni VL (2017). Usual choline intakes are associated with egg and protein food consumption in the United States. Nutrients. 9(8):839. — PubMed: Wallace NHANES 2017
- Yan J, Jiang X, West AA, Perry CA, Malysheva OV et al. (2012). Maternal choline intake modulates maternal and fetal biomarkers of choline metabolism in humans. Am J Clin Nutr. 95(5):1060-71. — PubMed: Yan 2012
- Poly C, Massaro JM, Seshadri S, Wolf PA, Cho E et al. (2011). The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring Cohort. Am J Clin Nutr. 94(6):1584-91. — PubMed: Poly Framingham 2011
- Boeke CE, Gillman MW, Hughes MD, Rifas-Shiman SL, Villamor E, Oken E (2013). Choline intake during pregnancy and child cognition at age 7 years. Am J Epidemiol. 177(12):1338-47. — PubMed: Boeke Project Viva 2013
- Strain JJ, McSorley EM, van Wijngaarden E, Kobrosly RW, Bonham MP et al. (2013). Choline status and neurodevelopmental outcomes at 5 years of age in the Seychelles Child Development Nutrition Study. Br J Nutr. 110(2):330-6. — PubMed: Strain Seychelles 2013
- Cheatham CL, Goldman BD, Fischer LM, da Costa KA, Reznick JS, Zeisel SH (2012). Phosphatidylcholine supplementation in pregnant women consuming moderate-choline diets does not enhance infant cognitive function: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 96(6):1465-72. — PubMed: Cheatham 2012
- Zeisel SH (2006). Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr. 26:229-50. — PubMed: Zeisel 2006
- Institute of Medicine (1998). Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. National Academies Press. — PubMed: IOM 1998
- Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS et al. (2011). Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 472(7341):57-63. — PubMed: Wang TMAO Nature 2011
- Cho CE, Taesuwan S, Malysheva OV, Bender E, Tulchinsky NF et al. (2017). Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: a randomized controlled trial. Mol Nutr Food Res. 61(1). — PubMed: Cho TMAO response 2017
- Resseguie M, Song J, Niculescu MD, da Costa KA, Randall TA, Zeisel SH (2007). Phosphatidylethanolamine N-methyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytes. FASEB J. 21(10):2622-32. — PubMed: Resseguie PEMT 2007
PubMed Topic Searches
- PubMed: Choline pregnancy brain
- PubMed: Phosphatidylcholine egg yolk
- PubMed: Choline NTD folate
- PubMed: TMAO cardiovascular
- PubMed: Choline AI deficiency NHANES